cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
复制标题

DOI:
10.1007/s00401-020-02127-9
复制
发表时间:
2020-03
影响因子:
12.7
通讯作者:
Weller M
Weller M
中科院分区:
医学1区
文献类型:
--
作者:
Brat DJ;Aldape K;Colman H;Figrarella-Branger D;Fuller GN;Giannini C;Holland EC;Jenkins RB;Kleinschmidt-DeMasters B;Komori T;Kros JM;Louis DN;McLean C;Perry A;Reifenberger G;Sarkar C;Stupp R;van den Bent MJ;von Deimling A;Weller M

文献摘要

参考文献

被引文献

相似文献

弥漫性胶质瘤IDH突变状态的诊断重要性首次在更新的第四版世卫组织中枢神经系统肿瘤分类(2016)中得到正式承认。它作为诊断标记物的引入是基于将生物标记物结合到综合诊断中提供了一种更具重复性和临床意义的成人弥漫性胶质瘤分类的证据[20-22]。对于IDH突变的弥漫性星形细胞胶质瘤,2016年WHO分类的综合诊断实体(及相应级别)包括弥漫性星形细胞瘤,
The diagnostic importance of IDH mutational status in diffuse gliomas was first formally recognized within the updated 4th edition of the WHO Classification of Tumours of the Central Nervous System (2016). Its introduction as a diagnostic marker was based on evidence that incorporation of biomarkers into an integrated diagnosis provided a more reproducible and clinically meaningful classification of diffuse gliomas in adults [20–22]. For IDH-mutant diffuse astrocytic gliomas, the integrated diagnostic entities (and corresponding grades) of the 2016 WHO Classification included diffuse astrocytoma,
国际神经病理学协会 - 哈勒姆神经系统肿瘤分类和分级共识指南。
DOI: 10.1111/bpa.12171
发表时间: 2014-09
期刊: Brain pathology (Zurich, Switzerland)
影响因子: --
作者:
Louis DN;Perry A;Burger P;Ellison DW;Reifenberger G;von Deimling A;Aldape K;Brat D;Collins VP;Eberhart C;Figarella-Branger D;Fuller GN;Giangaspero F;Giannini C;Hawkins C;Kleihues P;Korshunov A;Kros JM;Beatriz Lopes M;Ng HK;Ohgaki H;Paulus W;Pietsch T;Rosenblum M;Rushing E;Soylemezoglu F;Wiestler O;Wesseling P;International Society Of Neuropathology--Haarlem
通讯作者: International Society Of Neuropathology--Haarlem
DOI: 10.1007/s00401-015-1398-z
发表时间: 2015-04
影响因子: 12.7
作者:
Olar A;Wani KM;Alfaro-Munoz KD;Heathcock LE;van Thuijl HF;Gilbert MR;Armstrong TS;Sulman EP;Cahill DP;Vera-Bolanos E;Yuan Y;Reijneveld JC;Ylstra B;Wesseling P;Aldape KD
通讯作者: Aldape KD
DOI: 10.1056/nejmoa1407279
发表时间: 2015-06-25
期刊: The New England journal of medicine
影响因子: --
作者:
Eckel-Passow JE;Lachance DH;Molinaro AM;Walsh KM;Decker PA;Sicotte H;Pekmezci M;Rice T;Kosel ML;Smirnov IV;Sarkar G;Caron AA;Kollmeyer TM;Praska CE;Chada AR;Halder C;Hansen HM;McCoy LS;Bracci PM;Marshall R;Zheng S;Reis GF;Pico AR;O'Neill BP;Buckner JC;Giannini C;Huse JT;Perry A;Tihan T;Berger MS;Chang SM;Prados MD;Wiemels J;Wiencke JK;Wrensch MR;Jenkins RB
通讯作者: Jenkins RB
DOI: 10.1111/nan.12523
发表时间: 2019-02-01
影响因子: 5
作者:
Korshunov, A.;Casalini, B.;Sahm, F.
通讯作者: Sahm, F.
DOI: 10.1093/jnen/nly026
发表时间: 2018-07-01
影响因子: 3.2
作者:
Richardson, Timothy E.;Sathe, Adwait Amod;Hatanpaa, Kimmo J.
通讯作者: Hatanpaa, Kimmo J.